RJFSA
IRWD icon

Raymond James Financial Services Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Raymond James Financial Services Advisors’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$64.2K Buy
15,584
+254
+2% +$1.37K ﹤0.01% 3346
2024
Q2 		$100K Hold
15,330
– – ﹤0.01% 3230
2024
Q1 		$134K Hold
15,330
– – ﹤0.01% 3184
2023
Q4 		$175K Buy
15,330
+1,483
+11% +$14.7K ﹤0.01% 3028
2023
Q3 		$133K Buy
13,847
+76
+0.6% +$745 ﹤0.01% 3022
2023
Q2 		$147K Buy
13,771
+46
+0.3% +$494 ﹤0.01% 3000
2023
Q1 		$144K Sell
13,725
-92
-0.7% -$1.03K ﹤0.01% 2995
2022
Q4 		$171K Buy
13,817
+72
+0.5% +$817 ﹤0.01% 2905
2022
Q3 		$142K Sell
13,745
-303
-2% -$3.44K ﹤0.01% 2934
2022
Q2 		$162K Buy
14,048
+2,000
+17% +$23.6K ﹤0.01% 2914
2022
Q1 		$152K Buy
12,048
+85
+0.7% +$974 ﹤0.01% 3033
2021
Q4 		$139K Buy
11,963
+417
+4% +$5.12K ﹤0.01% 3072
2021
Q3 		$151K Hold
11,546
– – ﹤0.01% 3050
2021
Q2 		$149K Sell
11,546
-1,000
-8% -$11.4K ﹤0.01% 3081
2021
Q1 		$140K Buy
12,546
+1,000
+9% +$10.6K ﹤0.01% 2993
2020
Q4 		$132K Hold
11,546
– – ﹤0.01% 2821
2020
Q3 		$104K Buy
11,546
+150
+1% +$1.49K ﹤0.01% 2690
2020
Q2 		$118K Hold
11,396
– – ﹤0.01% 2610
2020
Q1 		$115K Hold
11,396
– – ﹤0.01% 2211
2019
Q4 		$152K Hold
11,396
– – ﹤0.01% 2638
2019
Q3 		$98K Sell
11,396
-200
-2% -$1.94K ﹤0.01% 2645
2019
Q2 		$127K Buy
+11,596
New +$130K ﹤0.01% 2644
2018
Q2 		– Sell
-13,711
Closed -$177K – 2820
2018
Q1 		$177K Hold
13,711
– – ﹤0.01% 2291
2017
Q4 		$172K Sell
13,711
-298
-2% -$3.89K ﹤0.01% 2304
2017
Q3 		$185K Sell
14,009
-511
-4% -$7.03K ﹤0.01% 2306
2017
Q2 		$230K Hold
14,520
– – ﹤0.01% 2126
2017
Q1 		$207K Buy
14,520
+1,072
+8% +$14.7K ﹤0.01% 2116
2016
Q4 		$172K Buy
+13,448
New +$170K ﹤0.01% 2106

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Raymond James Financial Services Advisors's IRWD Position: Q3 2024 in Review

Raymond James Financial Services Advisors increased its Ironwood Pharmaceuticals (IRWD) stake by 1.7% in Q3 2024, buying an estimated $1.37K and bringing the position to 15,584 shares worth $64.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3346.

Raymond James Financial Services Advisors first reported a position in IRWD in Q4 2016 and has held it in 28 quarters since. The position peaked at $230K in Q2 2017. 221 funds tracked by Wall St. Rank hold IRWD as of Q3 2024.

  • Raymond James Financial Services Advisors held 15,584 shares of Ironwood Pharmaceuticals worth $64.2K as of Q3 2024.
  • Raymond James Financial Services Advisors bought 254 Ironwood Pharmaceuticals shares in Q3 2024, an estimated $1.37K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #3346 holding.
  • Raymond James Financial Services Advisors first reported a position in Ironwood Pharmaceuticals in Q4 2016 and has held it in 28 quarters since.
  • Raymond James Financial Services Advisors's Ironwood Pharmaceuticals position peaked at $230K in Q2 2017.
  • 221 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.